Cost-Effectiveness Analysis of Four Therapeutic Schemes for Essential Hypertension
- VernacularTitle:4种用药方案治疗原发性高血压的成本-效果分析
- Author:
Bingkang ZHAO
;
Jinhua JIA
- Publication Type:Journal Article
- Keywords:
Essential hypertension;
Amlodipine;
Enalapril;
Hydrochlorothiazide;
Cost-effectiveness analysis
- From:
China Pharmacy
2005;0(17):-
- CountryChina
- Language:Chinese
-
Abstract:
0.05). Both the cost-effectiveness ratio and the ?C/?E in Group C were lower than in Group D. CONCLUSION: Group C is the best one in terms of cost-effectiveness.